Skip to main navigation
About us
Overview
Leadership
Contact
Our Portfolio
Radiopharmaceuticals
Pipeline
Naxitamab
Pipeline
Scientific resources
DANYELZA®
Partnerships
Resources
Overview
Patients & caregivers
Physicians
ISS Grant Submission
Investors
Investor Overview
News & Events
News Releases
Events & Presentations
Stock Information
Stock Quote & Chart
Analyst Coverage
Corporate Governance
Documents & Charters
Board of Directors
Leadership
Committee Composition
Financial Information
SEC Filings
Annual Reports
Quarterly Results
Investor Resources
Investor FAQs
Email Alerts
Contact IR
Careers
Main Menu
About us
Overview
Leadership
Contact
Our Portfolio
Radiopharmaceuticals
Pipeline
Naxitamab
Pipeline
Scientific resources
DANYELZA®
Partnerships
Resources
Overview
Patients & caregivers
Physicians
ISS Grant Submission
Investors
Investor Overview
News & Events
News Releases
Events & Presentations
Stock Information
Stock Quote & Chart
Analyst Coverage
Corporate Governance
Documents & Charters
Board of Directors
Leadership
Committee Composition
Financial Information
SEC Filings
Annual Reports
Quarterly Results
Investor Resources
Investor FAQs
Email Alerts
Contact IR
Careers
Main Menu
Event Details
Third Quarter 2020 Earnings Conference Call
Nov 06, 2020
9:00 AM EST
Listen to webcast
About us
Menu Toggle
Overview
Leadership
Contact
Our Portfolio
Menu Toggle
Radiopharmaceuticals
Pipeline
Naxitamab
Pipeline
Scientific resources
DANYELZA®
Partnerships
Resources
Menu Toggle
Overview
Patients & caregivers
Physicians
ISS Grant Submission
Investors
Menu Toggle
Investor Overview
News & Events
News Releases
Events & Presentations
Stock Information
Stock Quote & Chart
Analyst Coverage
Corporate Governance
Documents & Charters
Board of Directors
Leadership
Committee Composition
Financial Information
SEC Filings
Annual Reports
Quarterly Results
Investor Resources
Investor FAQs
Email Alerts
Contact IR
Careers
Scroll to Top
